| Hematopoietic Stem Cell Transplantation | Lifetime | 75 | CN 2 | 99.56 |
| Acute Myeloid Leukemia Research | Lifetime | 178 | CN 1 | 99.44 |
| Acute Lymphoblastic Leukemia research | Lifetime | 178 | CN 1 | 99.25 |
| Immune Cell Function and Interaction | Lifetime | 583 | CN 12 | 99.24 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 201 | CN 1 | 98.96 |
| T-cell and B-cell Immunology | Lifetime | 579 | CN 9 | 98.92 |
| CAR-T cell therapy research | Lifetime | 444 | CN 7 | 98.69 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 494 | CN 3 | 98.67 |
| Polyomavirus and related diseases | Lifetime | 166 | CN 2 | 98.22 |
| Mesenchymal stem cell research | Lifetime | 397 | CN 44 | 98.01 |
| Cytomegalovirus and herpesvirus research | Lifetime | 478 | CN 7 | 97.92 |
| Eosinophilic Disorders and Syndromes | Lifetime | 325 | CN 3 | 97.52 |
| Multiple Myeloma Research and Treatments | Lifetime | 594 | CN 11 | 97.11 |
| Retinoids in leukemia and cellular processes | Lifetime | 418 | CN 13 | 96.60 |
| Hematological disorders and diagnostics | Lifetime | 431 | CN 4 | 94.34 |
| Neutropenia and Cancer Infections | Lifetime | 578 | CN 5 | 95.36 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 731 | CN 11 | 95.18 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 4 | CN 1 | 99.77 |
| Immune Cell Function and Interaction | 2021-2025 | 43 | CN 8 | 99.14 |
| T-cell and B-cell Immunology | 2021-2025 | 48 | CN 2 | 98.20 |
| Acute Myeloid Leukemia Research | 2021-2025 | 75 | CN 2 | 99.22 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 51 | CN 1 | 98.90 |
| CAR-T cell therapy research | 2021-2025 | 149 | CN 9 | 98.91 |
| Cytomegalovirus and herpesvirus research | 2021-2025 | 46 | CN 3 | 96.12 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 80 | CN 2 | 98.45 |
| Polyomavirus and related diseases | 2021-2025 | 43 | CN 2 | 96.78 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 188 | CN 6 | 97.78 |
| Virus-based gene therapy research | 2021-2025 | 326 | CN 77 | 92.42 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 239 | CN 8 | 94.58 |
| Mesenchymal stem cell research | 2021-2025 | 255 | CN 91 | 92.07 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 178 | CN 5 | 92.11 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 447 | CN 4 | 92.47 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 542 | CN 32 | 92.87 |
| Platelet Disorders and Treatments | 2021-2025 | 325 | CN 29 | 90.72 |
| Neutropenia and Cancer Infections | 2021-2025 | 506 | CN 25 | 76.88 |
| Traditional Chinese Medicine and Integrative Care | 2021-2025 | 86 | CN 57 | 75.74 |
| Hematological disorders and diagnostics | 2021-2025 | 296 | CN 21 | 72.25 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 312 | CN 69 | 72.17 |
| Educational Reforms and Innovations | 2021-2025 | 188 | CN 108 | 70.35 |
| Parvovirus B19 Infection Studies | 2021-2025 | 723 | CN 111 | 59.51 |
| Holomorphic and Operator Theory | 2021-2025 | 745 | CN 135 | 55.78 |
